Patients with carcinomatous meningitis should also be excluded
Has known carcinomatous meningitis
Known carcinomatous meningitis
Carcinomatous meningitis, as defined by positive cytology
COHORT C: Carcinomatous meningitis, as defined by positive cytology
History of carcinomatous meningitis
Subjects with carcinomatous meningitis
History of carcinomatous meningitis
Presence or history of carcinomatous meningitis
Carcinomatous meningitis
Carcinomatous meningitis
Subjects with carcinomatous meningitis
Participants must not have carcinomatous meningitis
Subjects with carcinomatous meningitis.
Participants with carcinomatous meningitis
Patients with carcinomatous meningitis
Has known carcinomatous meningitis (also known as leptomeningeal disease)
CAPMATINIB EXCLUSION CRITERIA: Presence or history of carcinomatous meningitis
CERITINIB EXCLUSION CRITERIA: History of carcinomatous meningitis
History of carcinomatous meningitis
History of carcinomatous meningitis
Has carcinomatous meningitis;
Carcinomatous meningitis
Patients with carcinomatous meningitis should also be excluded
Subjects with carcinomatous meningitis
Subjects with carcinomatous meningitis
Subjects with carcinomatous meningitis
Has known carcinomatous meningitis, extracranial disease, or multifocal disease
Subjects with carcinomatous meningitis
Carcinomatous meningitis, which means there is inflammation of the covering of the brain, caused by cancer
Subjects with carcinomatous meningitis
Participants with carcinomatous meningitis
Leptomeningeal disease or carcinomatous meningitis
Carcinomatous meningitis
Carcinomatous meningitis
Presence of carcinomatous meningitis.
History of or known carcinomatous meningitis
Patients with carcinomatous meningitis
Patients with documented or suspected Candida meningitis.
Carcinomatous meningitis.
Known carcinomatous meningitis
Carcinomatous meningitis or leptomeningeal disease
History of carcinomatous meningitis.